Zika Virus Is Sweeping Across Central And South America, And Is Likely To Soon Enter The US. The Implications Of The Outbreak Are Examined In This Report.

11 September 2018
Pharma

A new report by visiongain studies the Zika virus outbreak that is current spreading through Central and South America. These insights appear in The Zika Virus Report: Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market, published February 2016. Visiongain is a business information provider based in London, UK.

The Zika Virus Report: Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market examines the current effects of the Zika outbreak, as well as the structure, reproduction, and outbreak history of the virus. Evidence is mounting regarding the serious complications that can accompany Zika infection, and these are explored in depth in this report.

Efforts are underway to develop new diagnostic tools for use in diagnosing Zika virus infection at point-of-care facilities, as well as to develop a vaccine to combat the spread of the disease. To support the case for this, the global infectious disease diagnostics market is forecast from 2016 to 2026, as is the global human vaccines market. The companies engaged in these efforts and their potential prolso outlined.

The spread of Zika virus could have serious social and economic impacts, including issues regarding contraducts are aception and abortion. Tourism is a major driver of economic growth in a number of countries that are either experiencing active transmission of Zika, or are at serious risk of doing so. The effects the virus could have on this industry are far reaching, some of which could result in further exacerbation of the outbreak. Using our experience and sources, we have compiled a comprehensive report on the potential impacts of this virus.

Jack Evans, a pharmaceutical and medical devices industry analyst in visiongain, said: “As Zika virus continues to spread across the Central and South America, evidence mounts for the correlation between Zika and microcephaly, as well as Zika and GBS. The rapid spread of Zika coupled with possible complications and imminent entrance into as yet unaffected regions has prompted major pharmaceutical companies to begin vaccine development for the virus. However, vaccine development remains in the early stages with having only entered preclinical trials. The virus could have a significant social and economic impact, with tourism an important regional industry. The Summer Olympics are taking place in Brazil in 2016, and Zika virus may have an effect on attendance numbers.”

The Zika Virus Report: Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.

Recent News

“In Vitro Diagnostics (IVD) market set to grow to $91bn by 2024” says new Visiongain report

In recent years, the IVD market has experienced increased consolidation among industry participants, with significant merger and acquisition (M&A) activity, especially among larger companies as they diversify and manoeuvre for stronger positions.

14 May 2019

Read

“Indian Pharmaceutical market set to grow to $71bn by 2024” says new Visiongain report

Expected increases in the level of healthcare coverage will allow greater proportion of the population to be able to afford medical care, which is still mostly paid for out-of-pocket by patients, as a greater amount of people have health insurance to cover their medical expenses.

09 May 2019

Read

“Global mRNA Vaccines and Therapeutics market set to grow to $5.5bn by 2024” says new Visiongain

The major drivers supporting the growth of the mRNA Vaccines and Therapeutics Market are rising adoption of personalized medicine for effective treatment, advantages offered by mRNA-based products, and rising funding by pharmaceutical companies and government organizations.

07 May 2019

Read

“Global Oncology Drugs market set to grow to $173bn by 2024” says new Visiongain report

The cancer treating drugs market will continue to grow over the next ten years.

03 May 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever
WOOCS 2.2.1